Classification: Psychedelic research chemical (with reported stimulating properties)
These chemicals have nearly no history of human use prior to 2010 when they first became available online.
The NBOMeN-Benzyl-Ortho-Methoxy derivatives of psychedelic phenethylamines. family of chemicals is relatively new and very little is known about this group of compounds. These chemicals may only be used with extreme caution.
Effects have been reported to vary very strongly by person (for example: person A gets a 4-hour body high with barely any visual aspects, while person B gets a >12 hour DOB-like trip with an intense visual aspect). NBOMeN-Benzyl-Ortho-Methoxy derivatives of psychedelic phenethylamines. chemicals are not active orallyRoute of administration in which the subject swallows a substance., and will not work if swallowed. It is recommended to avoid sublingual administrationRoute of administration in which the subject places a substance under the tongue. because of the reported bad taste. Buccal administrationRoute of administration in which the subject places a substance against their gums or other oral mucosa. is common, placing the tab between the upper or lower gum and lip.
Duration: 4-14 hours
Low dose: 200-500 ug (micrograms!)
Medium (typical) dose: 500-1500 ug (micrograms!)
High dose: >1500 ug (micrograms!)
Duration: 3-8 hours
Onset: 0-10 minutes
Low dose: 100 - 400 ug (micrograms!)
Medium (typical) dose: 400 - 700 ug (micrograms!)
High dose: >700 ug (micrograms!)
Effects have been reported to vary very strongly by person (for example: person A gets a 4-hour body high with barely any visual aspects, while person B gets a >12 hour DOB-like trip with an intense visual aspect).
Duration: 4-11 hours
Low dose: 100-300 ug (micrograms!)
Medium (typical) dose: 300-800 ug (micrograms!)
High dose: >800 ug (micrograms!)
Duration: 3-8 hours
Onset: 0-10 minutes
Low dose: 100-300 ug (micrograms!)
Medium (typical) dose: 300-500 ug (micrograms!)
High dose: >500 ug (micrograms!)
(likelihood of negative side effects increases with higher doses)
No reports of hangovers have been found.
An afterglow may be present until a day after use, sometimes more depending on the individual.
A relatively high rate of HPPD has been reported (all anecdotal data!) after the use of the NBOMeN-Benzyl-Ortho-Methoxy derivatives of psychedelic phenethylamines. chemicals.
Do not attempt to operate heavy machinery, drive, ride a bike or do anything similar. Delayed reaction time and altering of your visual perception make these kind of activities unsafe.
>2 weeks for a 100% tolerance reset, but the more time the better. You have only one body, be careful with it.
So far no reports of addiction have surfaced.
Most reports of death by an NBOMeN-Benzyl-Ortho-Methoxy derivatives of psychedelic phenethylamines. chemical involve mislabeling of the drug (for example: someone insufflates 20mg of 25i-NBOMeN-Benzyl-Ortho-Methoxy derivatives of psychedelic phenethylamines. because he/she thought it was 2C-I). This chemical is extremely potent and has a relatively low LD50The dosage of a substance at which 50% of the exposed subjects does not survive. To estimate the LD50 for humans, tests are conducted on non-human subjects. (LD50The dosage of a substance at which 50% of the exposed subjects does not survive. To estimate the LD50 for humans, tests are conducted on non-human subjects. is the dosage at which 50% of the tested population does not survive). Therefore, a mislabeling can result in death.
Do not use when you have a history of mental illness or a family history of mental illness (such as depression, schizophrenia, psychosis, bipolar disorder, etc.)
Do not use when you have a history of heart issues or a family history of heart issues.
italic caption
The -NBOMeN-Benzyl-Ortho-Methoxy derivatives of psychedelic phenethylamines. series of psychoactives became controlled in the Russian Federation starting October, 2011. See http://www.rg.ru/2011/10/19/narko-dok.html
The NBOMeN-Benzyl-Ortho-Methoxy derivatives of psychedelic phenethylamines. series of compounds are unscheduled in the United States. It is possible that some of them would be considered analogs (of scheduled phenethylamines such as 2C-B or mescaline), in which case, sales for human consumption or possession with the intent to ingest could be prosecuted under the Federal Analogue Act. However, Virginia has recently made the 25x-NBOMeN-Benzyl-Ortho-Methoxy derivatives of psychedelic phenethylamines. series and all its analogues schedule I; expected is that more states are to follow quickly.